 |
News Releases
2008
2006
2005
2004
|
|
|
| |
December 21, 2007 |
Protox Announces Stock Options Granted |
| |
November 27, 2007 |
Protox Releases Q3 2007 Financial Results And Company Highlights |
| |
November 20, 2007 |
Protox Receives $7.6 Million From Exercise Of Warrants |
| |
November 14, 2007 |
Protox Collaborates With Brainlab For Brain Cancer Program |
| |
November 1, 2007 |
Protox Announces Positive Final Data From Prostate Cancer Study |
| |
October 31, 2007 |
Protox To Present At Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference |
| |
October 26, 2007 |
Protox Receives $5.2 Million To Date From Exercise Of Warrants |
| |
October 25, 2007 |
Protox Modifies Terms Of Share Purchase Warrants |
| |
October 22, 2007 |
Protox Appoints Dr. Samuel Denmeade as Chief Scientific Officer |
| |
October 18, 2007 |
Protox Strengthens Patent Portfolio And Protection Of PRX302 |
| |
October 3, 2007 |
Protox Completes BPH Trial Recruitment And Announces Positive Interim Data |
| |
September 18, 2007 |
Protox Appoints Dr. Martin Gleave as Chair of Clinical Advisory Board |
| |
September 17, 2007 |
Protox to Present at the Admetech Foundation Conference |
| |
September 07, 2007 |
Protox To Present Interim Prostate Cancer Data At AUA Conference |
| |
August 30, 2007 |
Protox Releases Q2 2007 Financial Results And Company Highlights
|
| |
August 21, 2007 |
Protox Acquires Research Program From Medicenna
|
| |
July 17 , 2007 |
Protox Announces Manufacturing Agreement With Dompe For PRX321
|
| |
July 10 , 2007 |
Protox Announces Positive Clinical Data From Prostate Cancer Study |
| |
June 06 , 2007 |
Protox completes prostate cancer trial recruitment |
| |
May 17 , 2007 |
Protox releases Q1 2007 financial results and company highlights |
| |
May 08 , 2007 |
Protox to present at Bio 2007 |
| |
Apr 27, 2007 |
Protox reports 2006 financial results and achievements |
| |
Apr 24, 2007 |
Protox doses first patient in benign prostatic
hyperplasia trial using PRX302 |
|
Apr 24, 2007 |
Protox to present at BioFinance 2007 |
|
Mar 28, 2007 |
Protox initiates Phase 1 Study of PRX302 for Benign Prostatic Hyperplasia |
|
Mar 26, 2007 |
Protox Announces Senior Management Changes |
|
Mar 20, 2007 |
Protox Announces Publication in Journal of the National Cancer Institute Supporting PRX302 as Treatment for Prostatic Diseases |
|
Mar 8, 2007 |
Protox Therapeutics to Present at BioSquare 2007 |
|
Mar 1, 2007 |
Protox Outlines Milestones for 2007 |
|
Feb 23, 2007 |
Protox Announces PRX302 Data to be Presented at ASCO Sponsored Prostate Cancer Symposium |
|
Feb 22, 2007 |
Protox Anounces Stock Options Granted |
|
Feb 9, 2007 |
Protox Anounces Addition to Management Team |
|
Jan 18, 2007 |
Protox Reports Promising Interim Results From Prostate Cancer Study |
|
Jan 17, 2007 |
Protox Therapeutics Notice of Conference Call and Webcast |
|
|
|
